Fine-mapping inflammatory bowel disease loci to single-variant resolution
- PMID: 28658209
- PMCID: PMC5511510
- DOI: 10.1038/nature22969
Fine-mapping inflammatory bowel disease loci to single-variant resolution
Abstract
Inflammatory bowel diseases are chronic gastrointestinal inflammatory disorders that affect millions of people worldwide. Genome-wide association studies have identified 200 inflammatory bowel disease-associated loci, but few have been conclusively resolved to specific functional variants. Here we report fine-mapping of 94 inflammatory bowel disease loci using high-density genotyping in 67,852 individuals. We pinpoint 18 associations to a single causal variant with greater than 95% certainty, and an additional 27 associations to a single variant with greater than 50% certainty. These 45 variants are significantly enriched for protein-coding changes (n = 13), direct disruption of transcription-factor binding sites (n = 3), and tissue-specific epigenetic marks (n = 10), with the last category showing enrichment in specific immune cells among associations stronger in Crohn's disease and in gut mucosa among associations stronger in ulcerative colitis. The results of this study suggest that high-resolution fine-mapping in large samples can convert many discoveries from genome-wide association studies into statistically convincing causal variants, providing a powerful substrate for experimental elucidation of disease mechanisms.
Conflict of interest statement
The authors declare no competing financial interests.
Figures











Similar articles
-
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.Gastroenterology. 2015 Nov;149(6):1575-1586. doi: 10.1053/j.gastro.2015.07.065. Epub 2015 Aug 14. Gastroenterology. 2015. PMID: 26278503 Free PMC article.
-
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.Lancet. 2016 Jan 9;387(10014):156-67. doi: 10.1016/S0140-6736(15)00465-1. Epub 2015 Oct 18. Lancet. 2016. PMID: 26490195 Free PMC article.
-
The association of MYO9B gene in Italian patients with inflammatory bowel diseases.Aliment Pharmacol Ther. 2008 Feb 1;27(3):241-8. doi: 10.1111/j.1365-2036.2007.03551.x. Epub 2007 Oct 15. Aliment Pharmacol Ther. 2008. PMID: 17944996
-
Genetics of inflammatory bowel disease.Clin Sci (Lond). 1998 May;94(5):473-8. doi: 10.1042/cs0940473. Clin Sci (Lond). 1998. PMID: 9682668 Review.
-
The genetic background of inflammatory bowel disease: from correlation to causality.J Pathol. 2017 Jan;241(2):146-158. doi: 10.1002/path.4817. Epub 2016 Nov 15. J Pathol. 2017. PMID: 27785786 Review.
Cited by
-
Effect of all-but-one conditional analysis for eQTL isolation in peripheral blood.Genetics. 2023 Jan 12;223(1):iyac162. doi: 10.1093/genetics/iyac162. Genetics. 2023. PMID: 36321965 Free PMC article.
-
Heterozygous variants of NOD2, IL10RA, PLA2G6 and COL7A1 correlate with Crohn's disease.Heliyon. 2023 Nov 30;10(1):e22968. doi: 10.1016/j.heliyon.2023.e22968. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38163100 Free PMC article.
-
Prediction of the cell-type-specific transcription of non-coding RNAs from genome sequences via machine learning.Nat Biomed Eng. 2023 Jun;7(6):830-844. doi: 10.1038/s41551-022-00961-8. Epub 2022 Nov 21. Nat Biomed Eng. 2023. PMID: 36411359
-
Serum urate is associated with an increased risk of inflammatory bowel disease: A bidirectional Mendelian randomization study.World J Clin Cases. 2024 Feb 16;12(5):891-902. doi: 10.12998/wjcc.v12.i5.891. World J Clin Cases. 2024. PMID: 38414603 Free PMC article.
-
ANANASTRA: annotation and enrichment analysis of allele-specific transcription factor binding at SNPs.Nucleic Acids Res. 2022 Jul 5;50(W1):W51-W56. doi: 10.1093/nar/gkac262. Nucleic Acids Res. 2022. PMID: 35446421 Free PMC article.
References
-
- Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.e42. quiz e30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA141743/CA/NCI NIH HHS/United States
- U54 DE023789/DE/NIDCR NIH HHS/United States
- U01 DK062413/DK/NIDDK NIH HHS/United States
- P30 DK043351/DK/NIDDK NIH HHS/United States
- U24 DK062429/DK/NIDDK NIH HHS/United States
- U01 DK062432/DK/NIDDK NIH HHS/United States
- MR/M00533X/1/MRC_/Medical Research Council/United Kingdom
- U01 DK062429/DK/NIDDK NIH HHS/United States
- 098051/WT_/Wellcome Trust/United Kingdom
- U01 DK062422/DK/NIDDK NIH HHS/United States
- G0800759/MRC_/Medical Research Council/United Kingdom
- ETM/137/CSO_/Chief Scientist Office/United Kingdom
- R01 DK106593/DK/NIDDK NIH HHS/United States
- U01 DK062420/DK/NIDDK NIH HHS/United States
- R01 DK064869/DK/NIDDK NIH HHS/United States
- 098759/WT_/Wellcome Trust/United Kingdom
- U01 AI067068/AI/NIAID NIH HHS/United States
- P01 DK046763/DK/NIDDK NIH HHS/United States
- R01 DK092235/DK/NIDDK NIH HHS/United States
- G0600329/MRC_/Medical Research Council/United Kingdom